Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini

Xi, 2007, Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples, RNA, 13, 1668, 10.1261/rna.642907 1989, The general rules for the clinical and pathological study of primary liver cancer, Jpn J Surg, 19, 98, 10.1007/BF02471576 Khan, 2005, Cholangiocarcinoma, Lancet, 366, 1303, 10.1016/S0140-6736(05)67530-7 Sripa, 2011, Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos, Acta Trop, 120, S158, 10.1016/j.actatropica.2010.07.006 Sripa, 2007, Liver fluke induces cholangiocarcinoma, PLoS Med, 4, e201, 10.1371/journal.pmed.0040201 IARC. Schistosomes, liver flukes and helicobacter pylori. International Agency for Research on Cancer, World Health Organization; 1994. Cavalli, 2006, Cancer in the developing world: can we avoid the disaster?, Nat Clin Pract Oncol, 3, 582, 10.1038/ncponc0611 Keiser, 2010, Update on the diagnosis and treatment of food-borne trematode infections, Curr Opin Infect Dis, 23, 513, 10.1097/QCO.0b013e32833de06a Sripa, 2003, Pathobiology of opisthorchiasis: an update, Acta Trop, 88, 209, 10.1016/j.actatropica.2003.08.002 Woradet, 2013, Factors affecting survival time of cholangiocarcinoma patients: a prospective study in Northeast Thailand, Asian Pac J Cancer Prev, 14, 1623, 10.7314/APJCP.2013.14.3.1623 Nakajima, 1988, A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading, Hum Pathol, 19, 1228, 10.1016/S0046-8177(88)80156-4 Nakanuma, 2010, Pathological classification of intrahepatic cholangiocarcinoma based on a new concept, World J Hepatol, 2, 419, 10.4254/wjh.v2.i12.419 Pritchard, 2012, MicroRNA profiling: approaches and considerations, Nat Rev Genet, 13, 358, 10.1038/nrg3198 Braconi, 2008, MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumours, Hepatology, 47, 1807, 10.1002/hep.22326 Budhu, 2008, Identification of metastasis-related microRNAs in hepatocellular carcinoma, Hepatology, 47, 897, 10.1002/hep.22160 Karakatsanis, 2013, Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance, Mol Carcinog, 52, 297, 10.1002/mc.21864 Murakami, 2006, Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues, Oncogene, 25, 2537, 10.1038/sj.onc.1209283 Chen, 2009, The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma, J Hepatol, 50, 358, 10.1016/j.jhep.2008.09.015 Chusorn, 2013, Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumour growth and metastasis, Tumour Biol, 34, 1579, 10.1007/s13277-013-0688-0 Kawahigashi, 2009, MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs, J Nippon Med Sch, 76, 188, 10.1272/jnms.76.188 Plieskatt, 2014, Methods and matrices: approaches to identifying miRNAs for Nasopharyngeal carcinoma, J Transl Med, 12, 3, 10.1186/1479-5876-12-3 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 2002 Mayr, 2013, MicroRNAs within the continuum of postgenomics biomarker discovery, Arterioscler Thromb Vasc Biol, 33, 206, 10.1161/ATVBAHA.112.300141 Kruger, 2014, Molecular characterization of exosome-like vesicles from breast cancer cells, BMC Cancer, 14, 44, 10.1186/1471-2407-14-44 Jung, 2010, Robust microRNA stability in degraded RNA preparations from human tissue and cell samples, Clin Chem, 56, 998, 10.1373/clinchem.2009.141580 Weinbren, 1983, Pathological aspects of cholangiocarcinoma, J Pathol, 139, 217, 10.1002/path.1711390210 Han, 2011, MicroRNA expression signatures of bladder cancer revealed by deep sequencing, PLoS One, 6, e18286, 10.1371/journal.pone.0018286 Zang, 2014, Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma, Tumour Biol, 35, 3295, 10.1007/s13277-013-1432-5 Kolacinska, 2014, Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report, Mol Biol Rep, 41, 2851, 10.1007/s11033-014-3140-7 Gui, 2011, Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies, Clin Sci (Lond), 120, 183, 10.1042/CS20100297 Liu, 2014, Identification of serum microRNAs as diagnostic and prognostic biomarkers for acute pancreatitis, Pancreatology, 14, 159, 10.1016/j.pan.2014.03.019 Rizvi, 2013, Pathogenesis, diagnosis, and management of cholangiocarcinoma, Gastroenterology, 145, 1215, 10.1053/j.gastro.2013.10.013 Nakanuma, 2008, Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis, Hepatol Res, 38, 325, 10.1111/j.1872-034X.2007.00312.x Li, 2014, Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis, Hepatology Sun, 2010, microRNA: a master regulator of cellular processes for bioengineering systems, Annu Rev Biomed Eng, 12, 1, 10.1146/annurev-bioeng-070909-105314